| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA174897
Max Phase: Preclinical
Molecular Formula: C28H34O8
Molecular Weight: 498.57
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)Oc1ccc2c(OC(C)=O)c(C/C=C(\C)CCC3OC3(C)CCC3OC3(C)C)c(=O)oc2c1
Standard InChI: InChI=1S/C28H34O8/c1-16(8-12-24-28(6,36-24)14-13-23-27(4,5)35-23)7-10-21-25(33-18(3)30)20-11-9-19(32-17(2)29)15-22(20)34-26(21)31/h7,9,11,15,23-24H,8,10,12-14H2,1-6H3/b16-7+
Standard InChI Key: AIOZJPKGPZIFDO-FRKPEAEDSA-N
Associated Targets(non-human)
shc Squalene-hopene cyclase (47 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 498.57 | Molecular Weight (Monoisotopic): 498.2254 | AlogP: 5.03 | #Rotatable Bonds: 10 |
| Polar Surface Area: 107.87 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.60 | CX LogD: 3.60 |
| Aromatic Rings: 2 | Heavy Atoms: 36 | QED Weighted: 0.15 | Np Likeness Score: 1.77 |
References
| 1. Cravotto G, Balliano G, Robaldo B, Oliaro-Bosso S, Chimichi S, Boccalini M.. (2004) Farnesyloxycoumarins, a new class of squalene-hopene cyclase inhibitors., 14 (8): [PMID:15050630] [10.1016/j.bmcl.2004.01.085] |
Source
Source(1):